Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 38  |  Issue : 3  |  Page : 478-484

Management of infantile periorbital hemangiomas: a revisit


1 Department of Surgery, Divisions of Pediatric Surgery, Ophthalmology, College of Medicine; Department of Surgery, Division of Pediatric Surgery, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
2 Department of General Surgery, Division of Plastic Surgery, King Fahd Hospital of the University, Dammam, Egypt
3 Department of General Surgery, Division of Pediatric Surgery, Faculty of Medicine, Menoufia University, Menoufia, Egypt
4 Department of Surgery, Divisions of Pediatric Surgery, Ophthalmology, College of Medicine; Department of Surgery, Division of Plastic Surgery, King Fahd Hospital of the University, Qatif Central Hospital, Qatif, Saudi Arabia
5 Department of Surgery, Division of Pediatric Surgery, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
6 Department of Surgery, Divisions of Pediatric Surgery, Ophthalmology, College of Medicine, Saudi Arabia
7 Department of Vascular Surgery, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt
8 Department of Surgery, Division of Plastic Surgery, King Fahd Hospital of the University, Qatif Central Hospital, Qatif, Saudi Arabia

Correspondence Address:
MD Ossama M Zakaria
Department of Surgery, Divisions of Pediatric Surgery, Ophthalmology, College of Medicine, King Faisal University, Al Ahsa, Saudi Arabia
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ejs.ejs_41_19

Rights and Permissions

Background Although infantile hemangioma is a common benign childhood tumor, it is still one of the challenging problems. Aim The current prospective study aimed to evaluate the effect of local propranolol gel in the treatment of infantile periorbital hemangioma. Patients and methods A prospective study in the period of 4 years from January 2012 to December 2016 was carried out on infants with periorbital hemangioma with a follow-up period of a minimum of 1 year. All infants underwent a fine-needle histopathological sample. All patients who proved to be capillary hemangioma were divided into two groups. Group I included those patients who were treated with topical timolol maleate gel from 4 to 30 weeks. On the other hand, group II included those patients who underwent a local corticosteroid therapy in the form of clobetasol 0.05% gel for a similar period. Posttherapy clinical and histopathological assessment took place in both groups. The obtained data were statistically analyzed. Results Twenty-eight patients were enrolled in the study. They were 18 women and 10 men with the ratio of women to men being about 2 : 1. In 21 infants, the tumor shrank in a period of 4–10 weeks after topical timolol administration. On the other hand, those who underwent local corticosteroid therapy showed a longer period for the shrinkage of the tumor; the P value is less than 0.003. Conclusion Local timolol gel therapy is superior to topical corticosteroid therapy with a wide range of safety and less side effects. Moreover, its cost-effectiveness is acceptable compared with other modalities such as laser therapy. The number of the study materials are limited; yet, it may be an indicator for a road map of managing infantile periorbital hemangiomas. Further studies with a larger population may be needed, as the problem deserves a full citizenship in the world of pediatric research.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed224    
    Printed21    
    Emailed0    
    PDF Downloaded31    
    Comments [Add]    

Recommend this journal